CANY
BLFS icon

Caxton Associates (New York)’s BioLife Solutions BLFS Stock Holding History

Caxton Associates (New York)’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$314K Buy
+12,112
New +$301K 0.01% 400

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caxton Associates (New York)'s BLFS Position: Q4 2024 in Review

Caxton Associates (New York) opened a new position in BioLife Solutions (BLFS) in Q4 2024: 12,112 shares worth $314K. The stake represents 0.01% of the portfolio and ranks #400 among its holdings.

180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

  • Caxton Associates (New York) held 12,112 shares of BioLife Solutions worth $314K as of Q4 2024.
  • BioLife Solutions was a new Caxton Associates (New York) position in Q4 2024.
  • BioLife Solutions made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #400 holding.
  • 180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.